• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Advisory Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • Export Citation Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
AUT Journal of Modeling and Simulation
Articles in Press
Current Issue
Journal Archive
Volume Volume 49 (2017)
Issue Issue 2
Issue Issue 1
Volume Volume 48 (2016)
Volume Volume 47 (2015)
Volume Volume 46 (2014)
Volume Volume 45 (2013)
Volume Volume 44 (2012)
Volume Volume 43 (2011)
Volume Volume 42 (2010)
Volume Volume 41 (2009)
Abbasi, R., Hamidi Beheshti, M. (2017). PDC Control of Time Delay Fuzzy T-S modeled HIV-1 System through Drug Dosage. AUT Journal of Modeling and Simulation, 49(1), 33-42. doi: 10.22060/miscj.2016.839
R. Abbasi; M. T. Hamidi Beheshti. "PDC Control of Time Delay Fuzzy T-S modeled HIV-1 System through Drug Dosage". AUT Journal of Modeling and Simulation, 49, 1, 2017, 33-42. doi: 10.22060/miscj.2016.839
Abbasi, R., Hamidi Beheshti, M. (2017). 'PDC Control of Time Delay Fuzzy T-S modeled HIV-1 System through Drug Dosage', AUT Journal of Modeling and Simulation, 49(1), pp. 33-42. doi: 10.22060/miscj.2016.839
Abbasi, R., Hamidi Beheshti, M. PDC Control of Time Delay Fuzzy T-S modeled HIV-1 System through Drug Dosage. AUT Journal of Modeling and Simulation, 2017; 49(1): 33-42. doi: 10.22060/miscj.2016.839

PDC Control of Time Delay Fuzzy T-S modeled HIV-1 System through Drug Dosage

Article 4, Volume 49, Issue 1, Winter and Spring 2017, Page 33-42  XML PDF (4165 K)
Document Type: Research Article
DOI: 10.22060/miscj.2016.839
Authors
R. Abbasi1; M. T. Hamidi Beheshti 2
1Department of ElectricalEengineering, Islamic Azad University, Tehran, Iran
22 Department of Electrical & Computer, Tarbiat Modares University, Tehran, Iran
Abstract
This paper proposes a Time Delay nonlinear dynamic model of HIV-1 (Human Immunodeficiency Virus type 1), introducing the drug consumption efficiencies as the controlling input for the model. The paper also represents the fuzzy T-S representation and the corresponding Fuzzy T-S controller. The controller parameters are tuned using LMIs (Linear Matrix Inequalities). The main focus is on the stabilization problem for the resulting T-S fuzzy system with time-delay. In particular, it aims to present delay-dependent design of state feedback stabilizing fuzzy controller for the mentioned T-S fuzzy system with state delay. The design of the controller is based on the parallel distributed compensation.
Keywords
Fuzzy T-S; HIV-1; LMI; Control; Time Delay
References

[1]Joly, M., J. M. Pinto (2006). “Role of Mathematical Modeling on the Optimal Control of HIV-1 Pathogenesis”, PROCESS SYSTEMS ENGINEERING 52(3).

[2]Tanaka, K., H. O. Wang (2001). “FUZZY CONTROL SYSTEMS DESIGN AND ANALYSIS”, John Wiley & Sons.

[3]Kwon, O.M., et al. (2012). “Augmented Lyapunov– Krasovskii functional approaches to robust stability criteria for uncertain Takagi–Sugeno fuzzy systems with time-varying delays”, Fuzzy Sets and Systems 201: 1–19.

[4]Caetano, M. A. L., et al. (2008, June). “Optimal medication in HIV seropositive patient treatment using fuzzy cost function.” 2008 American Control Conference, Seattle, Washington, USA.

[5]Brandt, M. E., G. Chen (2001,July). “Feedback Control of a Biodynamical Model of HIV-1.” IEEE Transactions on Biomedical Engineering 48(7).

[6] Craig, I., X. Xia(2005,February). “Can HIV/AIDS Be Controlled? Applying control engineering concepts outside traditional fields.” IEEE Control Systems Magazine.

[7] Costanza, V., et al. (2009). “A closed-loop approach to antiretroviral therapies for HIV infection. “ Biomedical Signal Processing and Control 4: 139–148.

[8] Mhawej, M. J., et al. (2009). “Apoptosis characterizes immunological failure of HIV infected patients. “ Control Engineering Practice17: 798–804.

[9] Xia, X., (2003). “Estimation of HIV/AIDS parameters . “ Automatica 39: 1983 – 1988.

[10] Xia, X.,(2007). “Modeling of HIV infection: Vaccine readiness, drug effectiveness and therapeutical failures. “ Journal of Process Control 17: 253–260.

[11] Biafore, F. L., C. E. D’Attellis (2005,September). “Exact Linearisation and Control of a HIV-1 Predator-Prey Model. “ Proceedings of the 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference , Shanghai, China.

[12] Ge, S. S., et al. (2005,March). “Nonlinear Control of a Dynamic Model of HIV-1. “ IEEE Transactions on Biomedical Engineering 52(3).

[13] Jeffrey, A. M., X. Xia (2003,November). “When to Initiate HIV Therapy: A Control Theoretic Approach. “ IEEE Transactions on Biomedical Engineering 50(11).

[14] Elaiw, A. M., (2010). “Global properties of a class of HIV models. “ Nonlinear Analysis: Real World Applications 11: 2253_2263.

[15] Zurakowski, R., et al. (2004). “HIV treatment scheduling via robust nonlinear model predictive control. “ IEEE 2004 5th Asian Control Conference.

[16] Chang, H., A. Astolfi (2007,July). “Control of the HIV Infection Dynamics with a Reduced Second Order Model.“ Proceedings of the 2007 American Control Conference, New York City, USA.

[17] Chang, H., A. Astolfi (2009). “Enhancement of the immune system in HIV dynamics by output feedback. “ Automatica 45: 1765_1770.

[18] Chang, H.J., et al. (2004,December). “Control of Immune Response of HIV Infection Model by Gradual Reduction of Drug Dose. “ 43rd IEEE Conference on Decision and Control.

[19] Yongqi, L., S. Zhendong (2010,July). “Backward Bifurcation in an HIV Model with Two Target Cells.” Proceedings of the 29th Chinese Control Conference, Beijing, China.

[20] Chen, B. S., et al. (2010,July). “B. S. The Applications of Stochastic Regulation Control to HIV Therapy.“ Proceedings of the Ninth International Conference on Machine Learning and Cybernetics, Qingdao.

[21] Ledzewicz, U., H. Schattler (2002). “On optimal controls for a general mathematical model for chemotherapy of HIV. “ IEEE.

[22] Ko, J. H., et al.(2006,March). “Optimized Structured Treatment Interruption for HIV Therapy and Its Performance Analysis on Controllability.“ IEEE Transactions on Biomedical Engineering 53(3).

[23] Chang, H., A. Astolfi (2008,April). “Control of HIV Infection Dynamics. “ IEEE CONTROL SYSTEMS MAGAZINE.

[24] Pannocchia, G., et al. (2010,May). “A Model Predictive Control Strategy Toward Optimal Structured Treatment Interruptions in Anti-HIV Therapy. “ IEEE Transactions on Biomedical Engineering 57( 5).

[25] Mhawej, M. J., et al. (2010). “Control of the HIV infection and drug dosage. “ Biomedical Signal Processing and Control 5: 45–52.

[26] Barao, M., J.M. Lemos (2007). “Nonlinear control of HIV-1 infection with a singular perturbation model.” Biomedical Signal Processing and Control 2: 248–257.

[27] Gumel, A.B., S.M. Moghadas (2004). “HIV control in vivo: Dynamical analysis. “ Communications in Nonlinear Science and Numerical Simulation 9: 561–568.

[28] Orellana, J. M. (2010). “Optimal drug scheduling for HIV therapy efficiency improvement . “ Biomedical Signal Processing and Control.

[29] Wu, J., M. Zhang (2010,June) “A Game Theoretical Approach to Optimal Control of Dual Drug Delivery for HIV Infection Treatment. “ IEEE Transactions on Systems, Man, and Cybernetics—Part B: Cybernetics 40(3).

[30] Velichenko, V. V., D. A. Pritykin (2006). “Numerical Methods of Optimal Control of the HIV-Infection Dynamics.“ Journal of Computer and Systems Sciences International 45(6): 894–905.

[31] Luo, R., et al. (2009,June). “A Generalized Multi-strain Model of HIV Evolution with Implications for Drug-resistance Management.” 2009 American Control Conference Hyatt Regency Riverfront, St. Louis, MO, USA.

[32] Rong L., et al. (2007). “Modeling within-host HIV-1 dynamics and the evolution of drug resistance: Trade-offs between viral enzyme function and drug susceptibility . “ Journal of Theoretical Biology 247: 804–818.

[33] Banks, H. T., et al. (2005). “An SDRE Based Estimator Approach for HIV Feedback Control. “.

[34] Adams, B.M., et al. (2005). “Model Fitting and Prediction with HIV Treatment Interruption Data.”.

[35] Stan, G. B., et al. (2007). “Modelling the influence of activation-induced apoptosis of CD41 and CD81 T cells on the immune system response of a HIV-infected patient. “ IET Systems Biology.

[36] Singh, G. B. “Computational Modeling and Prediction of the Human Immunodeficiency Virus (HIV) Strains. “ IEEE.

[37] Shechter, S. M., et al. (2004). “MODELING THE PROGRESSION AND TREATMENT OF HIV.“ Proceedings of the IEEE 2004 Winter Simulation Conference.

[38] Spagnuolo, A. M., et al. (2004,September). “Modeling HIV-1 Dynamics and the Effects of Decreasing Activated Infected T-cell Count by Filtration.“ Proceedings of the 26th Annual International Conference of the IEEE EMBS, San Francisco, CA, USA.

[39] Marwala, T., B. Crossingham (2008). “Neuro-Rough Models for Modelling HIV.“ 2008 IEEE International Conference on Systems, Man and Cybernetics (SMC 2008).

[40] Ding, Y., H. Ye (2009). “A fractional-order differential equation model of HIV infection of CD4C T-cells.“ Mathematical and Computer Modeling 50: 386_392.

[41]Roy, P. K., et al. (2009,August). “HIV model with intracellular delay -a mathematical study.” 5th Annual IEEE Conference on Automation Science and Engineering Bangalore, India.

[42]Banks, H.T., et al. (2007). “Time delay systems with distribution dependent dynamics.” Annual Reviews in Control 31: 17–26.

[43]Banks, H.T., et al. (2003). “Incorporation of variability into the modeling of viral delays in HIV infection dynamics.” Mathematical Biosciences 183: 63–91.

[44]Lv, C., Z. Yuan (2009). “Stability analysis of delay differential equation models of HIV-1 therapy for fighting a virus with another virus.” Journal of Mathematical Analysis and Applications 352: 672–683.

[45]Xu, R., (2011). “Global dynamics of an HIV-1 infection model with distributed intracellular delays.” Computers and Mathematics with Applications 61: 2799–2805.

[46]Jiang, X., et al. (2008). “Analysis of stability and Hopf bifurcation for a delay-differential equation model of HIV infection of CD4+ T-cells.” Chaos, Solitons and Fractals 38: 447–460.

[47]Zhou, X., et al. (2008). “Analysis of stability and Hopf bifurcation for an HIV infection model with time delay .” Applied Mathematics and Computation 199: 23–38.

[48]Srivastava, P. Kr., P. Chandra, (2010). “Modeling the dynamics of HIV and CD4+T cells during primary infection.” Nonlinear Analysis: Real World Applications 11: 612_618.

[49]Nelson, P. W., et al. (2000). “A model of HIV-1 pathogenesis that includes an intracellular delay.” Mathematical Biosciences 163: 201-215.

[50]Wang, Y., et al. (2009). “Oscillatory viral dynamics in a delayed HIV pathogenesis model.” Mathematical Biosciences 219: 104–112.

[51]Nelson, P. W., A. S. Perelson (2002). “Mathematical analysis of delay differential equation models of HIV-1 infection.” Mathematical Biosciences 179: 73–94.

[52]Ouifki, R., G. Witten (2009). “Stability analysis of a model for HIV infection with RTI and three intracellular delays.” BioSystems 95: 1–6.

[53]Li, D., W. Ma, (2007). “Asymptotic properties of a HIV-1 infection model with time delay.” Journal of Mathematical Analysis and Applications 335: 683–691.

[54]Xu, R., (2011). “Global stability of an HIV-1 infection model with saturation infection and intracellular delay.” Journal of Mathematical Analysis and Applications 375: 75–81.

[55]Culshaw, R. V., S. Ruan (2000). “A delay-differential equation model of HIV infection of CD4+T-cells.” Mathematical Biosciences 165: 27-39.

[56]Guardiola, J., et al. (2003). “Simulating the Effect of Vaccine-Induced Immune Responses on HIV Infection .“ Human Immunology 64: 840–851.

[57]Hu, Z., et al. (2010). “Analysis of the dynamics of a delayed HIV pathogenesis model.“ Journal of Computational and Applied Mathematics 234: 461_476.

[58]Betechuoh, B. L., et al. (2008). “Computational Intelligence for HIV Modelling.” IEEE.

[59]Lin, F., et al. (2005,December). “Theory for a Control Architecture of Fuzzy Discrete Event Systems for Decision Making. “ Proceedings of the 44th IEEE Conference on Decision and Control, and the European Control Conference 2005, Seville, Spain.

[60]Melgarejo, M. A., et al. (2006,July). “A Genetic- Fuzzy System Approach To Control a Model of the HIV Infection Dynamics. “ 2006 IEEE International Conference on Fuzzy Systems, Vancouver, BC, Canada.

[61]Abbasi, R., M. T. H. Beheshti, (2015)”Modeling and stability analysis of HIV-1 as a Time Delay Fuzzy T-S system via LMI’s.” in press, Applied Mathematical Modeling 39( 23–24): 7134-7154.

[62]Wodarz, D., (2007). “Killer cell dynamics: Mathematical and computational approaches to immunology.” springer.

[63]Lin, C., et al. (2007). “LMI Approach to Analysis and Control of Takagi-Sugeno Fuzzy Systems with Time Delay.” Springer.

[64]Nentwig, M., P. Mercorelli (2010). “A Matlab/Simulink Toolbox for Inversion of Local Linear Model Trees.” IAENG International Journal of Computer Science, 37:1, IJCS_37_1_03.

[65]Fletcher, C. V., et al. (2014,February) “Persistent HIV- 1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues .” PNAS 111(6):2307–2312.

[66]Ene, L., et al. (2011). “How much do antiretroviral drugs penetrate into the central nervous system?. “ Journal of Medicine and Life 4(4): 432.439.

Statistics
Article View: 735
PDF Download: 282
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Amirkabir International Journal of Modeling, Identification, Simulation and Control is licensed under a
"Creative Commons Attribution 4.0 International (CC-BY 4.0)"

Amirkabir University of Technology (Tehran Polytechnic)

Journal Management System. Designed by sinaweb.